← Open Payments lookup

JIL SWANSON: Open Payments

NPI 1386792422 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$20,807 in 206 payments from 21 companies in 2025. Trend: 2023 $3,422 · 2024 $13,020 · 2025 $20,807

Speaker / faculty: $15,750Food & beverage: $3,932Travel & lodging: $1,124
CompanyPaymentsAmount
Janssen Biotech, Inc.45$17,945
Amgen Inc.11$390
GENZYME CORPORATION14$315
ABBVIE INC.37$297
Novartis Pharmaceuticals Corporation9$275
Lilly USA, LLC8$232
UCB, Inc.17$230
Galderma Laboratories, L.P.18$208
SUN PHARMACEUTICAL INDUSTRIES INC.7$156
MAYNE PHARMA COMMERCIAL LLC7$138

Products named: TREMFYA, OTEZLA, DUPIXENT, SKYRIZI, Bimzelx, EBGLYSS, NEMLUVIO, OPZELURA.

Industry payments across PA — which companies pay providers there.